Amylin CEO Talks Pricing Strategy

Daniel Bradbury, Amylin CEO, explains the company's pricing strategy in Europe and how it will catch up with rival Novo Nordisk. (CNBC)

MSNBC | January 30, 2012

Tags:. .nordisk. .bradbury. .novo. .rival. .ceo